Vivo Capital’s Aclaris Therapeutics ACRS Stock Holding History

Vivo Capital’s Portfolio ACRS Stock Details ACRS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.6M	Hold	8,888,888	–	–	1.29%	14
2025 Q1	$13.6M	Hold	8,888,888	–	–	1.8%	8
2024 Q4	$22M	Buy	+8,888,888	New	+$22M	2.47%	7
2023 Q4	–	Sell	-898,631	Closed	-$6.16M	–	49
2023 Q3	$6.16M	Hold	898,631	–	–	0.67%	34
2023 Q2	$9.32M	Hold	898,631	–	–	0.64%	25
2023 Q1	$7.27M	Hold	898,631	–	–	0.5%	25
2022 Q4	$14.2M	Hold	898,631	–	–	1.63%	18
2022 Q3	$14.1M	Hold	898,631	–	–	1.56%	20
2022 Q2	$12.5M	Hold	898,631	–	–	1.26%	22
2022 Q1	$15.5M	Sell	898,631 -22,351	-2%	-$385K	1.07%	22
2021 Q4	$13.4M	Sell	920,982 -19,772	-2%	-$287K	0.81%	29
2021 Q3	$16.9M	Sell	940,754 -433,525	-32%	-$7.8M	0.76%	26
2021 Q2	$24.1M	Sell	1,374,279 -272,935	-17%	-$4.79M	1.04%	23
2021 Q1	$41.5M	Hold	1,647,214	–	–	1.46%	15
2020 Q4	$10.7M	Hold	1,647,214	–	–	0.48%	39
2020 Q3	$4.23M	Hold	1,647,214	–	–	0.24%	54
2020 Q2	$2.67M	Hold	1,647,214	–	–	0.19%	51
2020 Q1	$1.71M	Buy	+1,647,214	New	+$1.71M	0.16%	48
2019 Q3	–	Sell	-1,647,214	Closed	-$3.61M	–	6
2019 Q2	$3.61M	Hold	1,647,214	–	–	0.34%	38
2019 Q1	$9.87M	Hold	1,647,214	–	–	0.98%	26
2018 Q4	$12.2M	Hold	1,647,214	–	–	1.55%	18
2018 Q3	$23.9M	Hold	1,647,214	–	–	2.41%	15
2018 Q2	$32.9M	Hold	1,647,214	–	–	4.24%	5
2018 Q1	$28.9M	Hold	1,647,214	–	–	4.09%	7
2017 Q4	$40.6M	Sell	1,647,214 -1,211,355	-42%	-$29.9M	8.7%	3
2017 Q3	$73.8M	Hold	2,858,569	–	–	14.91%	2
2017 Q2	$77.5M	Hold	2,858,569	–	–	19.52%	1
2017 Q1	$85.2M	Sell	2,858,569 -425,000	-13%	-$12.7M	25.08%	1
2016 Q4	$89.1M	Sell	3,283,569 -907,828	-22%	-$24.6M	29.37%	1
2016 Q3	$107M	Hold	4,191,397	–	–	33.45%	1
2016 Q2	$77.4M	Hold	4,191,397	–	–	21.14%	2
2016 Q1	$79.4M	Buy	+4,191,397	New	+$79.4M	19.92%	1